在老年人中对酒精预防干预措施的叙述性审查
Alexis Kuerbis1, Silke Behrendt2,3, Alex Elswick4
1Silberman School of Social Work, Hunter College, City University of New York, New York, New York.
Alcohol research : current reviews
|October 6, 2025
概括
对于老年人来说,有效的酒精预防干预措施至关重要. 调整干预措施以适应世代身份,而不仅仅是年龄,可以提高成功率,数字格式在所有年龄组都有效.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 酒精使用和酒精使用障碍 (AUD) 在50岁及以上的成年人中是一个日益严重的公共卫生问题.
- 现有的针对这一群体的预防干预措施研究受限于方法问题和狭窄的重点.
- 本次审查扩大了范围,包括多样化的研究设计和参与者子组,解决了先前文献中的差距.
研究的目的:
- 确定老年成人酒精预防干预措施的目标人群.
- 确定影响干预成功的障碍和促进因素.
- 纳入老年人和干预提供者的观点.
主要方法:
- 在多个数据库 (PubMed,PsycInfo等) 中进行了全面的文献搜索. 对于在1999年至2024年之间发表的研究.
- 纳入标准要求进行同行评审的研究,平均参与者年龄为55岁以上或50岁以上的子样本,重点关注非药物干预,并报告相关结果或观点.
- 综合了84个记录,详细介绍了51项干预和16篇视角文章,包括一系列研究设计.
主要成果:
- 大多数人体干预,主要是在初级保健中,在最伟大和沉默的一代中显示出酒精使用的显著减少.
- 沉默的一代始终表现出对干预措施的大量积极反应.
- 数字干预在包括婴儿潮一代在内的所有世代队列中都被证明是有效的,他们在一些随机对照试验中表现出显著的反应.
结论:
- 有效干预的障碍存在于组织,提供者和个人层面.
- 促进者包括饮酒跟踪,社会问责制和调整干预语调与老年人对饮酒的看法.
- 根据世代身份,文化和饮酒的意义来个性化干预是成功适应的关键.
更多相关视频
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
10.1K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.7K
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
187
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
187
01:15Drug Dosing: Geriatric Patients
225
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
225
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
196
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
196
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
234
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
234
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232